Quest Diagnostics SG&A Expenses 2010-2023 | DGX
Quest Diagnostics annual/quarterly sg&a expenses history and growth rate from 2010 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Quest Diagnostics sg&a expenses for the quarter ending December 31, 2023 were $0.407B, a 27.71% decline year-over-year.
- Quest Diagnostics sg&a expenses for the twelve months ending December 31, 2023 were $1.642B, a 12.38% decline year-over-year.
- Quest Diagnostics annual sg&a expenses for 2023 were $1.642B, a 12.38% decline from 2022.
- Quest Diagnostics annual sg&a expenses for 2022 were $1.874B, a 8.51% increase from 2021.
- Quest Diagnostics annual sg&a expenses for 2021 were $1.727B, a 11.42% increase from 2020.
Quest Diagnostics Annual SG&A Expenses
(Millions of US $) |
| 2023 |
$1,642 |
| 2022 |
$1,874 |
| 2021 |
$1,727 |
| 2020 |
$1,550 |
| 2019 |
$1,457 |
| 2018 |
$1,424 |
| 2017 |
$1,443 |
| 2016 |
$1,380 |
| 2015 |
$1,679 |
| 2014 |
$1,728 |
| 2013 |
$1,704 |
| 2012 |
$1,745 |
| 2011 |
$1,743 |
| 2010 |
$1,659 |
| 2009 |
$1,748 |
Quest Diagnostics Quarterly SG&A Expenses
(Millions of US $) |
| 2023-12-31 |
$407 |
| 2023-09-30 |
$380 |
| 2023-06-30 |
$416 |
| 2023-03-31 |
$439 |
| 2022-12-31 |
$563 |
| 2022-09-30 |
$464 |
| 2022-06-30 |
$422 |
| 2022-03-31 |
$425 |
| 2021-12-31 |
$464 |
| 2021-09-30 |
$427 |
| 2021-06-30 |
$429 |
| 2021-03-31 |
$407 |
| 2020-12-31 |
$447 |
| 2020-09-30 |
$396 |
| 2020-06-30 |
$360 |
| 2020-03-31 |
$347 |
| 2019-12-31 |
$349 |
| 2019-09-30 |
$362 |
| 2019-06-30 |
$362 |
| 2019-03-31 |
$384 |
| 2018-12-31 |
$356 |
| 2018-09-30 |
$354 |
| 2018-06-30 |
$351 |
| 2018-03-31 |
$363 |
| 2017-12-31 |
$382 |
| 2017-09-30 |
$348 |
| 2017-06-30 |
$358 |
| 2017-03-31 |
$355 |
| 2016-12-31 |
$99 |
| 2016-09-30 |
$409 |
| 2016-06-30 |
$430 |
| 2016-03-31 |
$442 |
| 2015-12-31 |
$429 |
| 2015-09-30 |
$402 |
| 2015-06-30 |
$429 |
| 2015-03-31 |
$419 |
| 2014-12-31 |
$427 |
| 2014-09-30 |
$446 |
| 2014-06-30 |
$440 |
| 2014-03-31 |
$415 |
| 2013-12-31 |
$415 |
| 2013-09-30 |
$423 |
| 2013-06-30 |
$418 |
| 2013-03-31 |
$448 |
| 2012-12-31 |
$421 |
| 2012-09-30 |
$417 |
| 2012-06-30 |
$424 |
| 2012-03-31 |
$483 |
| 2011-12-31 |
$386 |
| 2011-09-30 |
$447 |
| 2011-06-30 |
$463 |
| 2011-03-31 |
$448 |
| 2010-12-31 |
$382 |
| 2010-09-30 |
$427 |
| 2010-06-30 |
$419 |
| 2010-03-31 |
$431 |
| 2009-12-31 |
$433 |
| 2009-09-30 |
$442 |
| 2009-06-30 |
$449 |
| 2009-03-31 |
$424 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$15.639B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
